Exchange Traded Concepts, LLC Amneal Pharmaceuticals, Inc. Call Options Transaction History
Exchange Traded Concepts, LLC
- $10.4 Billion
- Q3 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding AMRX
# of Institutions
256Shares Held
146MCall Options Held
194KPut Options Held
49.3K-
Vanguard Group Inc Valley Forge, PA17.6MShares$197 Million0.0% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$138 Million6.02% of portfolio
-
Rubric Capital Management LP New York, NY11.7MShares$131 Million2.18% of portfolio
-
Black Rock Inc. New York, NY11.3MShares$126 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il5.62MShares$63 Million0.01% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.7B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...